z-logo
open-access-imgOpen Access
Adverse Outcome of Early Recurrent Ischemic Stroke Secondary to Atrial Fibrillation after Repeated Systemic Thrombolysis
Author(s) -
Luciano A. Sposato,
Valeria Salutto,
Diego E. Beratti,
Paula Monti,
Patricia M. Riccio,
Claudio Mazia
Publication year - 2013
Publication title -
case reports in vascular medicine
Language(s) - English
Resource type - Journals
eISSN - 2090-6986
pISSN - 2090-6994
DOI - 10.1155/2013/371642
Subject(s) - medicine , thrombolysis , atrial fibrillation , stroke (engine) , cardiology , middle cerebral artery , cerebral infarction , adverse effect , ischemic stroke , tissue plasminogen activator , infarction , anesthesia , ischemia , myocardial infarction , mechanical engineering , engineering
Background . Recurrent ischemic stroke is associated with adverse neurological outcome in patients with atrial fibrillation. There is very scarce information regarding the neurological outcome of atrial fibrillation patients undergoing repeated systemic thrombolysis after early recurrent ischemic stroke. Clinical Case and Discussion . We describe a case of a 76-year-old woman with known paroxysmal atrial fibrillation who was admitted because of an acute right middle cerebral artery ischemic stroke and who underwent repeated systemic thrombolysis within 110 hours. The patient underwent systemic thrombolysis after the first ischemic stroke with almost complete neurological recovery. On the fourth day after treatment, an acute left middle cerebral artery ischemic stroke was diagnosed and she was treated with full-dose intravenous recombinant tissue plasminogen activator. A hemorrhagic transformation of the left middle cerebral artery infarction was noted on follow-up cranial computed tomographic scans. The patient did not recover from the second cerebrovascular event and died 25 days after admission. Conclusion . To the best of our knowledge, this is the second case reporting the adverse neurological outcome of a patient with diagnosis of atrial fibrillation undergoing repeated systemic thrombolysis after early recurrent ischemic stroke. Our report represents a contribution to the scarce available evidence suggesting that repeated systemic thrombolysis for recurrent ischemic stroke should be avoided.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom